PTPN11 and Miyoshi myopathy: To explore the effect of SHP2 inhibitors on MM cell viability in vitro, RPMI-8226 and NCI-H929 cells were treated with gradually increasing concentrations of SHP099 or RMC-4550 for 24, 48, and 72 h.